BEGIN:VCALENDAR
PRODID:NingEventWidget-v1
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:2140535:Event:67821
DTSTAMP:20260411T221244Z
SUMMARY:Cancer Immunotherapy:  Advancing and Accelerating Discovery Pr
 ograms
DESCRIPTION:The most heralded new class of immuno-oncology drugs are t
 he immune checkpoint inhibitors, but with this excitement, comes a gro
 wing need for well-characterized preclinical models.\nIn this webinar,
   an evaluation of several syngeneic murine tumor models to antibody-
 based, immune checkpoint inhibitor therapeutics will be revealed. In a
 ddition, findings detailing the benefits of a multidisciplinary approa
 ch to cancer immunotherapy efficacy study design and execution will be
  outlined.\n\nFor more information visit https://medtechiq.ning.com/ev
 ents/cancer-immunotherapy-advancing-and-accelerating-discovery
DTSTART;TZID=America/New_York:20160125T110000
DTEND;TZID=America/New_York:20160125T120000
CATEGORIES:webinar, "(free)"
LOCATION:Online
WEBSITE:http://xtalks.com/Cancer-Immunotherapy.ashx
URL:http://xtalks.com/Cancer-Immunotherapy.ashx
CONTACT:416-977-6555
ORGANIZER;CN="Xtalks Life Science Webinars":https://medtechiq.ning.com
 /profile/Xtalks
ATTACH;FMTTYPE="image/jpeg":http://storage.ning.com/topology/rest/1.0/
 file/get/2562013012?profile=original
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE;CN="Xtalks L
 ife Science Webinars":https://medtechiq.ning.com/profile/Xtalks
END:VEVENT
END:VCALENDAR